Myant believes that the acquisition will expand its market reach in the US. Image credit: fizkes via Shutterstock.

Myant has acquired digital health company mmHg to advance its remote patient monitoring provision for cardiovascular care.

The Canadian company, which produces connected textiles that sense and react to the human body, said the acquisition formed part of a broader strategy of “prevention through precision to drive forward a new era of personalised, artificial intelligence-enabled remote healthcare”.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Myant also anticipates that the acquisition will expand its geographic footprint and market reach in the US, given mmHg’s existing relationship with medical device and health product manufacturer A&D Medical.

Utilised by institutions such as Beth Israel Deaconess at Harvard Medical and Johns Hopkins University, mmHg’s platform enables healthcare providers to remotely track and analyse blood pressure and other cardiovascular indicators.

With the acquisition, Myant asserts that the combination of mmHg’s remote monitoring capabilities with its material and textile computing technology will enable healthcare providers to access continuous, real-time patient data for “earlier detection of health risks, personalised treatment plans, and better management of chronic conditions”.

Myant CEO Tony Chahine commented: “Our company is on a mission to make healthy ageing a reality for millions.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

“We want to turn the tide on chronic conditions and redefine what it means to grow older. This acquisition enhances our ability to offer comprehensive cardiovascular monitoring and risk management solutions, strengthening our role in transforming digital health and enabling this large ageing demographic to live younger, longer.”

Terms of the deal and the timeline for completion have not been disclosed.

MmHg’s co-founder and chief operating officer Peter Wood said: “The combination of Myant’s cutting-edge textile technology and mmHg’s clinically-infused software architecture will no doubt create the next generation of personalised care delivery, where patients will be able to transmit clinical-grade, continuous vitals data feeds to a platform that presents the data in an efficient and clinically relevant manner to care teams.”

According to GlobalData market analysis, the global patient monitoring market will reach a valuation of around $15bn by 2033.

Last November, Myant concluded the acquisition of Switzerland-based textile computing companies Nanoleq and Osmotex at an undisclosed sum.